Managing OUD with Buprenorphine: Clinical Pearls
Psychopharmacology and Psychiatry Updates
Release Date: 07/20/2025
Antidepressants Beyond Depression: Applications in Bulimia Nervosa
Psychopharmacology and Psychiatry Updates
In this episode, we explore evidence-based pharmacotherapy for bulimia nervosa, including why higher doses of SSRIs work better than standard dosing, which medications to avoid completely, and how antidepressants can be effective even without depression being present. Why does fluoxetine require 60 mg daily for optimal results? Faculty: Scott Crow M.D. Host: Richard Seeber, M.D.
info_outline
Metformin and Antipsychotic-Induced Weight Gain: An Evidence-Based Solution
Psychopharmacology and Psychiatry Updates
In this episode, we explore groundbreaking research on managing antipsychotic-induced weight gain through a comprehensive network meta-analysis. Could the combination of low-dose metformin and lifestyle modifications be the game-changer that helps patients maintain both mental stability and physical health? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D.
info_outline
Monthly Injections, Long-Term Recovery: Naltrexone for OUD
Psychopharmacology and Psychiatry Updates
In this episode, we explore extended-release naltrexone for opioid use disorder, examining its unique role as a pure antagonist in patients who require safety-sensitive careers. How do we successfully navigate the challenging initiation period when patients must be opioid-free for a week? Faculty: Smita Das, M.D. Host: Richard Seeber, M.D.
info_outline
Antipsychotics and Aspiration Risk
Psychopharmacology and Psychiatry Updates
In this episode, we explore the surprising link between antipsychotic medications and pneumonia risk. Did you know that pneumonia is the fourth leading cause of death in schizophrenia patients, and certain medications increase this risk in unexpected ways? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D.
info_outline
Buprenorphine, Methadone, and Naltrexone: Helping Patients with OUD Decide
Psychopharmacology and Psychiatry Updates
In this episode, we explore how to choose between methadone, buprenorphine, and naltrexone for opioid use disorder treatment. With over 100,000 overdose deaths annually, how do we match the right medication to save each patient's life? Faculty: Smita Das, M.D. Host: Richard Seeber, M.D.
info_outline
Managing OUD with Buprenorphine: Clinical Pearls
Psychopharmacology and Psychiatry Updates
In this episode, we explore buprenorphine management for opioid use disorder, covering induction protocols, dosing strategies, and long-term maintenance. Why do patients need to be in withdrawal before starting this life-saving medication, and how can we make this challenging process more manageable? Faculty: Smita Das, M.D. Host: Richard Seeber, M.D.
info_outline
Valproate Weight Gain: Do Lower Doses Help?
Psychopharmacology and Psychiatry Updates
In this episode, we explore groundbreaking research on valproate's dose-dependent weight gain effects. Could prescribing lower doses be the key to maintaining therapeutic benefits while minimizing one of psychiatry's most challenging side effects? Dr. Paul Zarkowski reveals surprising findings that could transform your valproate prescribing approach. Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D.
info_outline
Methadone for Opioid Use Disorder
Psychopharmacology and Psychiatry Updates
In this episode, we explore methadone maintenance therapy for opioid use disorder, covering dosing strategies, recent regulatory changes, and safety considerations. Why do so many patients fail on methadone despite its proven effectiveness, and how can proper dosing make the difference between recovery and relapse? Faculty: Smita Das, M.D. Host: Richard Seeber, M.D.
info_outline
Clozapine and Compulsions: New Research On An Old Side Effect
Psychopharmacology and Psychiatry Updates
In this episode, we explore the puzzling connection between clozapine and obsessive-compulsive symptoms in schizophrenia patients. Does this wonder drug actually cause OCD, or are we missing a deeper story about how protective behaviors transform into compulsive habits? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.
info_outline
Naltrexone vs. Topiramate: FDA-Approved vs. Off-Label Options for MAUD
Psychopharmacology and Psychiatry Updates
In this episode, we explore groundbreaking head-to-head research comparing topiramate and naltrexone for alcohol use disorder, revealing surprising equivalence in effectiveness. Could the off-label option actually be as good as our FDA-approved standard for treating problematic drinking? Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D.
info_outlineIn this episode, we explore buprenorphine management for opioid use disorder, covering induction protocols, dosing strategies, and long-term maintenance. Why do patients need to be in withdrawal before starting this life-saving medication, and how can we make this challenging process more manageable?
Faculty: Smita Das, M.D.
Host: Richard Seeber, M.D.